Perceptive Advisors’s scPharmaceuticals SCPH Stock Holding History

Perceptive Advisors’s Portfolio SCPH Stock Details SCPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-583,142	Closed	-$3.31M	–	125
2025 Q3	$3.31M	Buy	583,142 +83,142	+17%	+$426K	0.1%	76
2025 Q2	$1.91M	Hold	500,000	–	–	0.07%	72
2025 Q1	$1.31M	Hold	500,000	–	–	0.05%	77
2024 Q4	$1.77M	Buy	+500,000	New	+$1.92M	0.05%	86
2023 Q1	–	Sell	-952,380	Closed	-$6.83M	–	107
2022 Q4	$6.83M	Buy	+952,380	New	+$5.82M	0.19%	65

Perceptive Advisors's SCPH Position: Q4 2025 in Review

Perceptive Advisors sold out of scPharmaceuticals (SCPH) in Q4 2025, closing a stake of 583,142 shares — an estimated $3.31M sold.

Perceptive Advisors first reported a position in SCPH in Q4 2022 and held it in 5 quarters. The position peaked at $6.83M in Q4 2022. 0 funds tracked by Wall St. Rank hold SCPH as of Q4 2025.

Perceptive Advisors reported no remaining scPharmaceuticals position as of Q4 2025 after selling out during the quarter.
Perceptive Advisors sold 583,142 scPharmaceuticals shares in Q4 2025, an estimated $3.31M.
Perceptive Advisors first reported a position in scPharmaceuticals in Q4 2022 and held it in 5 quarters.
Perceptive Advisors's scPharmaceuticals position peaked at $6.83M in Q4 2022.
0 funds tracked by Wall St. Rank held scPharmaceuticals as of Q4 2025.

Based on Perceptive Advisors's 13F filing for Q4 2025, filed 17 Feb 2026.